![Ron Hebert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ron Hebert
Vertrieb & Marketing bei COVALON TECHNOLOGIES LTD.
Profil
Ron Hebert is currently the Senior Vice President-Marketing at Covalon Technologies Ltd.
Prior to this, he worked as the Director-Global Product Management & Strategy at Beckman Coulter, Inc., Head-Growth & Sales Operations at Pediatrix Medical Group, Inc., and Vice President-Marketing & Communications at Vivex Biologics, Inc.
Aktive Positionen von Ron Hebert
Unternehmen | Position | Beginn |
---|---|---|
COVALON TECHNOLOGIES LTD. | Vertrieb & Marketing | 26.04.2022 |
Ehemalige bekannte Positionen von Ron Hebert
Unternehmen | Position | Ende |
---|---|---|
PEDIATRIX MEDICAL GROUP, INC. | Vertrieb & Marketing | - |
Beckman Coulter, Inc.
![]() Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | - |
Vivex Biologics, Inc.
![]() Vivex Biologics, Inc. BiotechnologyHealth Technology Vivex Biologics, Inc. is a regenerative medicine company that specializes in developing naturally sourced treatment options and solutions to improve clinical, surgical, and therapeutic patient care through innovation. The company is based in Atlanta, GA and has subsidiaries in the United States. The company leverages the resources of the nation's oldest civilian tissue bank to channel the body's inherent healing qualities and provide medical professionals and patients with innovative treatment options for a broad range of indications. With tissue damage resulting from a variety of diseases, direct injury, and trauma, there is a significant need for advanced solutions. The company was founded by Tracy S. Anderson, and Peter L. Wehrly has been the CEO of the company since 2019. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
COVALON TECHNOLOGIES LTD. | Health Technology |
PEDIATRIX MEDICAL GROUP, INC. | Health Services |
Private Unternehmen | 2 |
---|---|
Beckman Coulter, Inc.
![]() Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Vivex Biologics, Inc.
![]() Vivex Biologics, Inc. BiotechnologyHealth Technology Vivex Biologics, Inc. is a regenerative medicine company that specializes in developing naturally sourced treatment options and solutions to improve clinical, surgical, and therapeutic patient care through innovation. The company is based in Atlanta, GA and has subsidiaries in the United States. The company leverages the resources of the nation's oldest civilian tissue bank to channel the body's inherent healing qualities and provide medical professionals and patients with innovative treatment options for a broad range of indications. With tissue damage resulting from a variety of diseases, direct injury, and trauma, there is a significant need for advanced solutions. The company was founded by Tracy S. Anderson, and Peter L. Wehrly has been the CEO of the company since 2019. | Health Technology |